Why stocks are in for a rough ride this week
Stocks in for a rough ride this week

Longtime market bull Jeremy Siegel says investors could realize the market is behind the curve on interest rates.


Builders get upgraded at Raymond James, as do several energy stocks at Barclays.

By MSN Money Partner Nov 30, 2011 4:51PM
Noteworthy upgrades include:
  • Anadarko (APC) upgraded to Overweight from Equal Weight at Barclays
  • Nexen (NXY) upgraded to Overweight from Equal Weight at Barclays
  • Cenovus Energy (CVE) upgraded to Overweight from Equal Weight at Barclays
  • Transocean (RIG) upgraded to Hold from Trim at Tudor Pickering
  • Navistar (NAV) upgraded to Neutral from Sell at Goldman
  • Toll Brothers (TOL) upgraded to Outperform from Market Perform at Raymond James
  • D.R. Horton (DHI) upgraded to Outperform from Market Perform at Raymond James
  • Lennar (LEN) upgraded to Outperform from Market Perform at Raymond James

The tobacco company expects significant market share gains in Japan, Indonesia, Philippines, South Korea and Vietnam.

By Trefis Nov 30, 2011 4:47PM
Image: Man smoking (© Steve Mason/Photodisc Blue/Getty Images)Philip Morris International (PM), the leading international tobacco company outside the U.S. and China, recently provided more optimistic estimates of global cigarette industry volume trends at a Morgan Stanley conference in New York.

PMI expects cigarette volume (outside the U.S.) to increase as much as 1.3% a year over the next five years -- an improved outlook compared with previous forecasts. Philip Morris International competes with British American Tobacco (BTI), Japan Tobacco and Imperial Tobacco Group (IMT) in its various geographical segments. 

Investors are cheering a decision by the Federal Reserve to pump cheaper dollars into eurozone banks. Yet this merely treats a symptom, not the disease. And it won't save the euro.

By Anthony Mirhaydari Nov 30, 2011 4:27PM

Image: Hand hiding banknotes under vest, studio shot (© Mike Kemp/Rubberball/Getty Images)All week, the U.S. stock market was curiously buoyant as the eurozone crisis deepened. Wednesday morning, we learned why: The Federal Reserve, in cooperation with major central banks around the world, reduced the cost of providing dollar liquidity to banks in need from 1% over the rate set in the market to 0.5% over.


This unleashed a surge of buying, short covering, and cheerfulness as initial scans of the headlines seemed to suggest the Fed was riding to Europe's rescue. Not quite.


The Fed is merely postponing the inevitable, treating a symptom (bank funding problem) not the disease (a solvency crisis amongst eurozone governments).


The stock is downgraded to 'underperform' by a prominent analyst who says the company is broken.

By Kim Peterson Nov 30, 2011 3:55PM
Updated 4:35 p.m. ET

On a day when stocks soared, Netflix's (NFLX) drop was particularly jarring.

The stock just can't catch a break after passing $300 in July. Its plunge since then has been breathtaking, with shares closing at $64.53 Wednesday.

The day's fall was triggered largely by a downgrade from one of the more prominent analysts covering the stock. Michael Pachter of Wedbush Morgan said in a research note to investors that the company is broken. 
Tags: NFLX

Increasing competition in its core business has forced the company to offer value-add services to augment its product portfolio and protect margins.

By Trefis Nov 30, 2011 3:11PM
Akamai (AKAM) may be planning to buy software company Cotendo for more than $300 million, according to a report published in the Calcalist Financial daily Sunday.

Cotendo, a smaller Israeli rival which competes with Akamai for value-added services, was founded in 2008 and launched in March of last year. The company has raised more than $36 million in funding from Sequoia Capital, Benchmark Capital and other investors, and also has the backing of strategic partners such as Citrix, Juniper (JNPR), Google (GOOG) and AT&T (T). 

But a few are more likely to sell than others. Here are some names.

By Motley Fool Pick of the Day Nov 30, 2011 3:08PM

Image: Pills (© Corbis)By Brian Orelli


Another day, another buyout rumor. Monday, it was Onyx Pharmaceuticals (ONXX) that jumped after Bloomberg said the company was in the early stages of exploring the possibility of putting itself up for sale. Before that it wasAchillion Pharmaceuticals (ACHN). And BioSante Pharmaceuticals (BPAX) before that. The rumor list is a mile long.


Here's a news flash for you: Every public biotech could be sold at any point.


New credit downgrades to a number of banks by S&P and still-negative chart patterns mean Bank of America and Citigroup are still very much out of favor.

By MoneyShow.com Nov 30, 2011 2:43PM

Image: bank ATM (© Image Source/Corbis/Corbis)By Tom Aspray, MoneyShow.com

After the stock market close on Tuesday, S&P downgraded 15 big banks to reflect the results of its new credit criteria. Though many of the banks had been prepared for a downgrade, others immediately wondered about the impact on a fragile stock market.

The low-volume decline last week followed by Monday’s strong surge has kept the rally from the October lows intact, but it order to reverse the negative momentum, a strong weekly close is needed.


Bargain-shopping will never save us, and spending isn't as strong as some would believe.

By InvestorPlace Nov 30, 2011 1:46PM

Image: Santa Claus (© Corbis)By Jeff Reeves, InvestorPlace.com

A lot of hay has been made lately about the return of American consumers and the resurgence of retail. Yes, holiday sales got off to a bang as shoppers spent a record $52.4 billion over the Black Friday weekend -- up 16.4% from 2010. Yes, Cyber Monday sales also blew the virtual doors off, if early projections of $1.2 billion hold true.

But let's not fool ourselves. Unemployment remains above 9%. Serious debt woes continue to plague America and Europe. And the broader economic troubles lurk like an unrepentant Scrooge.


The much-awaited offering of the online gaming company may not be as overpriced as you might expect.

By The Fiscal Times Nov 30, 2011 1:21PM

Image: Couple with laptop (© Daly and Newton/OJO Images/Getty Images)By Suzanne McGee, The Fiscal Times

Got an avid FarmVille player among your family members or Facebook friends? The much-ballyhooed initial public offering of online gaming company Zynga (which counts FarmVille among its offerings) is apparently finally on track for the week before Christmas.

You might want to consider giving shares in the company in the hopes that the FarmVille players on your list will recoup some of what they've paid to Zynga for "gold" and other virtual items.

Tags: IPO

The increases show that the shipping company is confident in its business and its per-package revenue growth.

By Trefis Nov 30, 2011 1:06PM
UPS (UPS) has outlined details of its 2012 rate hike, which includes a net increase of 4.9% on all domestic and international packages.

The higher rates incorporate a reduction in fuel surcharges, which will fall by one percentage point for ground packages and two percentage points for domestic and international air mail. Freight charges are also set to rise, with next-day air freight and two-day air freight facing an increase of 5.9%. Three-day freight charges will remain unchanged. 
Tags: FDXups

If the Supreme Court says yes, it could cost the industry billions.

By Melly Alazraki Nov 30, 2011 12:59PM

Labor disputes are common in the auto and airline industries but not so much in the pharmaceutical sector. Yet a dispute between pharmaceutical companies and their drug reps could have such serious implications for the entire industry that both sides petitioned the Supreme Court to take on a current case. On Monday the petition was granted.

The court is now set to decide whether GlaxoSmithKline (GSK) has to pay overtime benefits to its sales representatives. What the court decides will have ramifications for similar cases against other Big Pharmas, including Merck (MRK), Novartis (NVS), Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) to name a few.


Could the social-networking site handle a massive offering all by itself?

By Jonathan Berr Nov 30, 2011 12:40PM
Image: Stock market Traders (© Photodisc/SuperStock)Facebook's $10 billion initial public offering, expected next year, is the among the most eagerly anticipated deals in recent memory. Wall Street bankers, though, may be sitting on the sidelines.

According to the Wall Street Journal, Facebook chief financial officer David Ebersman "has told bankers he is skeptical about the value bankers could bring to such a deal." That nugget, courtesy of anonymous sources, was designed to make the masters of the universe who arrange multi-billion dollar deals quake in their $695 Gucci loafers. It probably worked. 

Though the insurance company has been facing headwinds, there are long-term reasons for investor optimism.

By TheStockAdvisors Nov 30, 2011 11:16AM
Image: Insurance (© Hemera/age fotostock)By Richard Moroney, Dow Theory Forecasts

Aflac (AFL) ought to be reveling in its own success. As the top seller of cancer and medical insurance products in Japan, Aflac produces predictable cash flows from premiums on these policies.

But the shares have been volatile, reflecting its fight against the currents of Japan’s natural disaster and Europe’s debt crisis.

The company has grown sales 7% and per-share profits 14% over the last year, and expectations are for modest growth in 2012 (8% in sales and 4% in per-share profits). 
Tags: AFL

A coordinated intervention by the world's central banks to pump money and liquidity into the system suggests things in Europe are worse than we thought.

By Jim Cramer Nov 30, 2011 10:56AM

the street

Image: Bank Vault (© Radius Images/Jupiterimages)Things are much worse than I thought. For me, that's the real takeaway from this financial D-Day, this worldwide coordination from wealthier countries to help major banks in Europe that were clearly about to go under.


Remember, there were two risks to the situation: credit to the banks and credit to the countries. Apparently the credit had all but dried up for SocGen, for BNPParibas and maybe even for Deutsche Bank (DB). Now that credit will be freed up.


Zacks ranks this specialty retailer a strong buy and expects to see double digit earnings growth this year.

By Zacks.com Nov 30, 2011 10:45AM

By: Tracey Ryniec


Genesco Inc. (GCO), a specialty shoe and hat retailer, is in the sweet spot for retailing. This Zacks #1 Rank (strong buy) is expected to see double digit earnings growth this year. Shares recently soared to a new multi-year high. But surprisingly, GCO is also a value stock, with a forward P/E of 14.7.


Being involved in retail since 1924, Genesco has seen its share of both good and bad economies. Headquartered in Nashville, it now operates 2,225 footwear and headwear retail stores in the U.S., Canada and Puerto Rico.

Tags: GCO


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

120 rated 1
268 rated 2
439 rated 3
709 rated 4
641 rated 5
609 rated 6
640 rated 7
516 rated 8
272 rated 9
152 rated 10

Top Picks

TAT&T Inc9

Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market finished the Thursday session on a higher note with the S&P 500 climbing 0.5%. The benchmark index registered an early high within the first 90 minutes and inched to a new session best during the final hour of the action.

Equities rallied out of the gate with the financial sector (+1.1%) providing noteworthy support for the second day in a row. The growth-oriented sector extended its September gain to 1.9% versus a more modest uptick of 0.4% for the ... More


There’s a problem getting this information right now. Please try again later.